Image courtesy google

Neuralink, a brain-chip startup founded by billionaire entrepreneur Elon Musk, has obtained permission to kick off its first human trial. The focus of the clinical study will be on patients suffering from paralysis caused by cervical spinal cord injuries or amyotrophic lateral sclerosis (ALS). The announcement came on September 19 although the specific number of participants remains undisclosed

However, the final number approved by the FDA has not been confirmed. This latest development comes after Neuralink got the nod for its first-in-human clinical trial in May, a time when it was also under federal investigation for its animal testing practices.

At the heart of this pioneering trial is an intricate surgical process. A robot will place the BCI implant into a specific brain area responsible for the intention to move. The immediate aim is straightforward: enable the test subjects to operate a computer keyboard or move a cursor merely by using their thoughts.

https://be5bbqbr84o1g-jhlpsnx-dz2e.hop.clickbank.net